NCT03912610

Brief Summary

By the method of multi-mode Magnetic Resonance Imaging, 5 patients with knee osteoarthritis are selected in this trial to observe the possible differences in the brain structure and function from the 5 healthy volunteers.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
5

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2019

Typical duration for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 4, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 11, 2019

Completed
20 days until next milestone

Study Start

First participant enrolled

May 1, 2019

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2022

Completed
Last Updated

April 12, 2019

Status Verified

April 1, 2019

Enrollment Period

2.9 years

First QC Date

April 4, 2019

Last Update Submit

April 10, 2019

Conditions

Keywords

Osteoarthritis of kneeDepressive SymptomsAnxiety StateBrain Structure and FunctionMulti-mode Magnetic Resonance Imaging

Outcome Measures

Primary Outcomes (1)

  • blood-oxygen-level dependent (BOLD) signal

    BOLD is used in functional magnetic resonance imaging (fMRI) to observe different areas of the brain or other organs, which are found to be active at any given time. The hemoglobin content, blood flow volume and oxygen consumption of special brain regions will be observed via BOLD. Oxyhemoglobin ratio is used in this measurement.

    the data will be collected the second day when entering group

Study Arms (2)

Health control group

5 health volunteer are included in the group. Each volunteer will take the functional magnetic resonance examination one to collect the data.

Diagnostic Test: Functional magnetic resonance examination

Knee osteoarthritis group

5 patients of knee osteoarthritis accompanied with depression or anxiety are included in the group. Each volunteer will take the functional magnetic resonance examination one to collect the data.

Diagnostic Test: Functional magnetic resonance examination

Interventions

Functional magnetic resonance examination by a Ultra high field magnetic resonance instrument named MAGNATOM 7T.

Health control groupKnee osteoarthritis group

Eligibility Criteria

Age35 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study is a single-center randomized controlled clinical trial. It is expected to enroll 5 patients with knee osteoarthritis in the third affiliated hospital of zhejiang university of traditional Chinese medicine and recruit 5 healthy volunteers at the same time.

You may qualify if:

  • The experimental group was selected as:
  • Meet the above diagnostic criteria.
  • VAS scale score \> 4 points.
  • HAMA score \> 14 or HAMD score \> 17 points.
  • Agree to participate in the survey and submit an informed consent form.
  • The control group was selected as:
  • Healthy volunteers who exclude knee osteoarthritis.
  • VAS scale score ≤ 4 points.
  • HAMA score ≤14 or HAMD score ≤ 17 points.
  • Agree to participate in the survey and submit an informed consent form

You may not qualify if:

  • Rheumatoid arthritis, psoriatic arthritis, gouty arthritis, bone erosion, bone tuberculosis, bone tumor patients.
  • Clear diagnosis of traumatic meniscus, cruciate ligament, collateral ligament injury history and patients with history of knee trauma in the past six months.
  • Have a heavier heart, brain and other medical conditions and poor overall health.
  • In pregnancy, pregnancy or lactation.
  • Taking antidepressant and anxiety drugs.
  • Participated in other clinical studies within 2 months prior to the start of the study.
  • The patient or his licensor is unwilling to sign a written informed consent or is unwilling to follow the research protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Tang S, Lu L, Zhang L, Hu X, Bu X, Li H, Hu X, Gao Y, Zeng Z, Gong Q, Huang X. Abnormal amygdala resting-state functional connectivity in adults and adolescents with major depressive disorder: A comparative meta-analysis. EBioMedicine. 2018 Oct;36:436-445. doi: 10.1016/j.ebiom.2018.09.010. Epub 2018 Oct 11.

    PMID: 30316866BACKGROUND
  • Ye J, Shen Z, Xu X, Yang S, Chen W, Liu X, Lu Y, Liu F, Lu J, Li N, Sun X, Cheng Y. Abnormal functional connectivity of the amygdala in first-episode and untreated adult major depressive disorder patients with different ages of onset. Neuroreport. 2017 Mar 1;28(4):214-221. doi: 10.1097/WNR.0000000000000733.

    PMID: 28118287BACKGROUND
  • Spati J, Hanggi J, Doerig N, Ernst J, Sambataro F, Brakowski J, Jancke L, grosse Holtforth M, Seifritz E, Spinelli S. Prefrontal thinning affects functional connectivity and regional homogeneity of the anterior cingulate cortex in depression. Neuropsychopharmacology. 2015 Jun;40(7):1640-8. doi: 10.1038/npp.2015.8. Epub 2015 Jan 19.

    PMID: 25598428BACKGROUND

MeSH Terms

Conditions

Osteoarthritis, KneeDepressionAnxiety Disorders

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesBehavioral SymptomsBehaviorMental Disorders

Study Officials

  • Yuanyuan Wu, Master

    the Third affilliated Hospital of Zhejiang Chinese Medicine University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yuanyuan Wu, Doctor

CONTACT

Jingjing Zeng, Master

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
The officer of Science and Education Division

Study Record Dates

First Submitted

April 4, 2019

First Posted

April 11, 2019

Study Start

May 1, 2019

Primary Completion

April 1, 2022

Study Completion

April 1, 2022

Last Updated

April 12, 2019

Record last verified: 2019-04